MedTrace Logo

Role of Interleukin-6 in Exercise

NCT01073826 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2016-11-01

No results posted yet for this study

Summary

The purpose of the study is to understand the role of interleukin-6 during physical activity in patients with type 2 diabetes.

Conditions

  • Diabetes Mellitus, Type 2
  • Obesity

Interventions

BEHAVIORAL

Sport

DRUG

Tocilizumab

DRUG

Sitagliptin

Sponsors & Collaborators

  • European Foundation for the Study of Diabetes

    collaborator OTHER

  • University of Zurich

    lead OTHER

Principal Investigators

  • 01 Studienregister MasterAdmins · UniversitaetsSpital Zuerich

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2015-11-30
Completion
2016-06-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01073826 on ClinicalTrials.gov